Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

105.27
Delayed Data
As of Jan 24
 -3.28 / -3.02%
Today’s Change
94.59
Today|||52-Week Range
141.86
-2.66%
Year-to-Date

Today’s Trading

Previous close108.55
Today’s open109.05
Day’s range104.64 - 109.15
Volume2,071,611
Average volume (3 months)1,778,191
Market cap$25.1B
Data as of 4:15pm ET, 01/24/2020

Growth & Valuation

Earnings growth (last year)-82.40%
Earnings growth (this year)+31.38%
Earnings growth (next 5 years)+13.00%
Revenue growth (last year)+17.00%
P/E ratio16.1
Price/Sales5.29
Price/Book2.76

Competitors

 Today’s
change
Today’s
% change
SGENSeattle Genetics Inc-1.78-1.54%
INCYIncyte Corp-1.50-1.92%
GLPGGalapagos NV-0.74-0.32%
ALNYAlnylam Pharmaceutic...+2.04+1.73%
Data as of 4:00pm ET, 01/24/2020

Financials

Next reporting dateJanuary 30, 2020
EPS forecast (this quarter)$2.58
Annual revenue (last year)$4.1B
Annual profit (last year)$77.6M
Net profit margin1.88%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Boston, Massachusetts

Forecasts